# Phase 1b, Open-label Study of Tune-401 to Assess Safety, PK and PD in Adults With Chronic Hepatitis B

> **NCT06671093** · PHASE1 · RECRUITING · sponsor: **Tune Therapeutics, Inc.** · enrollment: 36 (estimated)

## Conditions studied

- Chronic Hep B
- Chronic Hepatitis b
- Chronic Hepatitis
- HBV

## Interventions

- **GENETIC:** Tune-401

## Key facts

- **NCT ID:** NCT06671093
- **Lead sponsor:** Tune Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-29
- **Primary completion:** 2028-06-28
- **Final completion:** 2028-10-30
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2026-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06671093

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06671093, "Phase 1b, Open-label Study of Tune-401 to Assess Safety, PK and PD in Adults With Chronic Hepatitis B". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT06671093. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*